Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ophthalmology
•
Uveitis and Ocular Immunology
When would you consider discontinuing immunosuppressive treatment in a quiescent uveitis patient without systemic manifestations of inflammation?
Related Questions
How do you manage checkpoint inhibitor-associated Vogt-Koyanagi-Harada (VKH) disease in patients who have poorly controlled diabetes?
How do you decide between initiating systemic immunosuppressive therapy versus controlling the uveitis with local treatment in a patient with HLA-B27 positive uveitis and a history of spondyloarthropathy?
How do approach perioperative steroids for a quiescent uveitis patient undergoing cataract surgery?
When would you consider using selective laser trabeculoplasty (SLT) for managing uveitic glaucoma?
Would you consider using a JAK inhibitor for a patient with RA associated scleritis?
How do you differentiate between ocular involvement due to active tuberculosis versus latent infection in a patient with uveitis and suspected tuberculosis?
How do you manage macular-threatening toxoplasma chorioretinitis in pregnancy?
How would you approach management of nodular scleritis in the setting of suspected GCA?
How do you approach the management of recurrent episcleritis in a patient with RA that is otherwise well-controlled?
What is your approach to antiviral treatment of HSV acute retinal necrosis?
